Cecelia R Miller
Overview
Explore the profile of Cecelia R Miller including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
58
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Avenarius M, Huang Y, Kittai A, Bhat S, Rogers K, Grever M, et al.
Leukemia
. 2024 Feb;
38(3):676-678.
PMID: 38374409
No abstract available.
2.
Teierle S, Huang Y, Kittai A, Bhat S, Grever M, Rogers K, et al.
Blood Adv
. 2023 Oct;
7(23):7239-7242.
PMID: 37851900
No abstract available.
3.
Avenarius M, Huang Y, Hyak J, Byrd J, Bhat S, Grever M, et al.
Hematol Oncol
. 2023 Apr;
41(4):771-775.
PMID: 37010242
Fluorescence in situ hybridization (FISH) to detect the recurrent cytogenetics abnormalities deletion 13q, trisomy 12, deletion 11q, and deletion 17p is important for prognostication in chronic lymphocytic leukemia (CLL). A...
4.
Hyak J, Huang Y, Rogers K, Bhat S, Grever M, Byrd J, et al.
Blood Adv
. 2022 Jul;
6(17):5124-5127.
PMID: 35834733
No abstract available.
5.
Miller C, Huang Y, Ruppert A, Labanowska J, Jaglowski S, Maddocks K, et al.
Leukemia
. 2021 Apr;
35(11):3287-3290.
PMID: 33820961
No abstract available.
6.
Avenarius M, Miller C, Arnold M, Koo S, Roberts R, Hobby M, et al.
J Mol Diagn
. 2020 Aug;
22(10):1238-1245.
PMID: 32745614
Somatic variants, primarily fusion genes and single-nucleotide variants (SNVs) or insertions/deletions (indels), are prevalent among sarcomas. In many cases, accurate diagnosis of these tumors incorporates genetic findings that may also...
7.
Miller C, Lee K, Pfau R, Reshmi S, Corsmeier D, Hashimoto S, et al.
Cold Spring Harb Mol Case Stud
. 2020 May;
6(3).
PMID: 32371413
Exome sequencing (ES) has become an important tool in pediatric genomic medicine, improving identification of disease-associated variation due to assay breadth. Depth is also afforded by ES, enabling detection of...
8.
Miller C, Heerema N
Methods Mol Biol
. 2018 Oct;
1881:27-34.
PMID: 30350195
Chromosome analysis of chronic lymphocytic leukemia (CLL) is an important clinical tool for evaluating prognosis and disease progression. Visualizing chromosomes microscopically using traditional cytogenetic techniques requires dividing cells to be...
9.
Miller C, Ruppert A, Heerema N, Maddocks K, Labanowska J, Breidenbach H, et al.
Blood Adv
. 2018 Jan;
1(19):1584-1588.
PMID: 29296799
Ibrutinib is a highly effective targeted therapy for chronic lymphocytic leukemia (CLL). However, ibrutinib must be discontinued in a subset of patients due to progressive CLL or transformation to aggressive...
10.
Miller C, Ruppert A, Fobare S, Chen T, Liu C, Lehman A, et al.
Oncotarget
. 2017 Apr;
8(16):25942-25954.
PMID: 28412730
The study of long noncoding RNAs (lncRNAs) is an emerging area of cancer research, in part due to their ability to serve as disease biomarkers. However, few studies have investigated...